WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Resear

June 4, 2026
Seven-year collaboration puts WellSpan at the forefront of diagnostics and imaging in community health through a groundbreaking research and innovation strategy aimed at shaping the future of care delivery
Amsterdam and YORK, Pa. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and WellSpan Health, the leading health care system in Central Pennsylvania and Northern Maryland, today announced a landmark seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The alliance is the latest addition to WellSpan’s growing innovation ecosystem, positioning the system as a national leader in the application of artificial intelligence and technology in health care.

"As WellSpan has grown in clinical capability, so has our responsibility to be more intentional about how we plan, deploy and support the life-saving technology our teams and patients rely on," said Roxanna Gapstur, Ph.D., R.N., WellSpan president and CEO. "This collaboration gives us that foundation, bringing consistency and coordination across our entire system, advancing digital and AI-enabled care and building a leading research and co-development platform that will transform the future of health care. Community health systems like WellSpan are where most Americans receive care, and we are proving they belong at the center of health care innovation."
The collaboration includes a research agreement and joint innovation strategy, the first of its kind between Philips and a U.S. community health system, which will focus on validating the performance of new tools and technology. Research is expected to examine how AI and digital tools are improving throughput, cost and workflow efficiency, aimed at advancing WellSpan's commitment to reclaim more than half a million hours of workforce time annually.
In addition, the innovation component of this relationship will allow WellSpan, together with Philips Research, to co-develop net-new products and features that advance care delivery. This work will draw on Philips' R&D pipeline to design and develop future generations of health care technology, with WellSpan serving as both a proving ground and a co-creator.
A long-term commercial agreement establishes Philips as WellSpan’s preferred vendor across all applicable imaging modalities (CT, MR, digital X-ray, ultrasound, and image-guided therapy). The agreement covers all 12 WellSpan hospitals, as well as its diagnostic imaging centers and ambulatory surgery centers, ensuring a consistent experience for patients wherever they need care. A defining feature of the commercial agreement is its structured approach to technology lifecycle management: WellSpan and Philips will align equipment, service, training and upgrade planning under a single coordinated framework, enabling more consistent imaging availability across sites, reducing gaps in access for patients and laying the foundation for continued innovation.
“This collaboration builds on a long-standing relationship between Philips and WellSpan, and it also marks an important evolution in how we work together,” said Roy Jakobs, CEO, Royal Philips. “By combining our health technology leadership with WellSpan’s clinical expertise and research focus, we’re creating a long-term alliance designed to drive measurable improvements in patient care quality, operational performance and innovation. Together, we’re establishing a scalable, AI-driven, platform-based approach that supports clinicians today while shaping how care is delivered in the future.”
*The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.
Contact:
Avi Dines
Philips North America
Tel: +1-781-690-3814
Email: avi.dines@philips.com
Jayme Maniatis
Philips Global External Relations
Tel.: +1 617 894 8368
E-mail: jayme.maniatis@philips.com
Contact:
Ryan Coyle
WellSpan Health
Tel: +1-717-851-3151
Email: RCoyle@WellSpan.org
About WellSpan Health
WellSpan Health’s vision is to reimagine healthcare through the delivery of comprehensive, equitable health and wellness solutions throughout our continuum of care. As an integrated delivery system focused on leading in value-based care, we encompass more than 2,700 employed providers, more than 250 locations, 12 award-winning hospitals, home care and a behavioral health organization serving Central Pennsylvania and Northern Maryland. Our high-performing Medicare Accountable Care Organization (ACO) is the region’s largest and one of the best in the nation. With a team 23,000 strong, WellSpan experts provide a range of services, from wellness and employer services solutions to advanced care for complex medical and behavioral conditions. Our clinically integrated network of 3,000 aligned physicians and advanced practice providers is dedicated to providing the highest quality and safety, inspiring our patients and communities to be their healthiest.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
- 第七届中国家装职业技能大赛暨第一届“菲尼杯”艺术涂装工技能大赛南宁赛区圆满落幕
- 莆田如何办理注册香港公司办理香港公司审计等流程指南
- 茶颂东方,香承罗马 宝格丽传奇之茶系列焕新庆典礼赞传承新生
- 福建微麦传媒:点亮普通人的抖商逆袭之路
- 福山无界·2026吉安武功山越野赛,圆满落幕
- 《金牌河东狮吼》上线发布爱虐交织片花 新版李月娥程季常上演旷世人妖恋
- 2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Da
- 克服“成功的诅咒”:AESC 的算法央行如何为物理经济重写 Web3 宏观经济学
- Curtiss-Wright和Sintavia交付首个配备增材制造叶轮的潜艇部件,将用于美国海军舰艇
- 短剧《云深不知处》开播!夫妻十年,丈夫竟要挖了她的眼给白月光?
- 高奢胸假体 | 泉州海峡整形&优丝俪福建新品首发上市会成功举办!
- “胰腺疾病诊疗智能体”在中关村论坛隆重发布
- 中信银行临汾分行扎实做好金融“五篇大文章”
- 三伏天执法无忧!ZECN致业记录仪助您高温暴雨从容应对
- 优团科技推出2024发现精彩生活计划 投入千万孵化休娱达人主播
- 第137届广交会成功举办 采购商到会和出口成交双增长 外贸新动能加速释放
- WorkJam宣布获得Export Development Canada 2,000万美元投资以扩大国际业务
- 锡林郭勒盟携手中国石油 蒙牛集团 打造锡林郭勒羊区域公用品牌溢价“金渠道”
- 从“愁白头”到“笑开颜”:一位项目总工的大跨度气膜突围记
- 长城人寿八达岭赤兔版年金险获评“金貔貅·年度金牌创新力金融产品”奖
- Dark Horse Consulting Group 与 Altruist Biologics 宣布签署谅解备忘录,共同推进中国生物制剂生产与开发
- Staffbase unveils the first AI-native Employee Experience Platform
- 欧派木门 晓伟整装,装点梦想家园,精品生活从这里开始!
- 北京环球度假区“酷爽夏日”将于6月12日高能回归 五周年夏日任你盛放
- AGA江海迦巡回演唱会广州站 Kelly陈慧琳惊喜现身任嘉宾合唱《熏衣草》
- Lessengers 发布业界首款用于AI/ML工作负载的部分重定时800G光收发器
- “互联网+”赋能五金行业升级,中国五金制品网引领新变革!
- Axi 将参加 2025 年哥伦比亚金融博览会,助力您拓展 IB 和联属业务
- 创新产品 共话未来|创维光伏亮相2024中国国际光储大会
- “黎城核桃”区域公用品牌及核桃企业亮相 “第二十二届绿博会”





